- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Study supports Acusphere agent
A study presented at last month’s American College of Cardiology meeting indicates that an ultrasound contrast agent under development by Acusphere of Cambridge, MA, could be used in a continuous mode. Imaging continuously with AI-700 could
A study presented at last months American College of Cardiology meeting indicates that an ultrasound contrast agent under development by Acusphere of Cambridge, MA, could be used in a continuous mode. Imaging continuously with AI-700 could help clinicians overcome some of the shortcomings of other agents, which have short persistence times because their contrast-enhancing microbubbles break up under ultrasound beams. Acusphere believes that the AI-700 microbubbles may have longer persistence times because they are made from synthetic polymers. AI-700 is in phase I clinical trials.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
